Chen W T, Olden K, Bernard B A, Chu F F
J Cell Biol. 1984 Apr;98(4):1546-55. doi: 10.1083/jcb.98.4.1546.
Virus-transformed fibroblasts show an increased production of proteases as well as loss of extracellular adhesive proteins. To determine whether these transformation-associated events are related, we investigated the capacity of Rous sarcoma virus-transformed cells (embryonic chick fibroblasts and mouse BALB/c 3T3) to degrade fibronectin by using a novel cross-linked protein substratum: fluorescence-labeled or radiolabeled fibronectin covalently linked to the surface of a fixed gelatin film. In serum-containing medium, the coupled fibronectin was not released when incubated without cells, and only a small amount was released when incubated with nontransformed cells. However, when transformed cells were seeded on the radiolabeled fibronectin-coupled substratum, there was a threefold increase in the time-dependent release of radioactivity into the medium. The released material was characterized as peptides with molecular sizes of less than 30,000 daltons. Correspondingly, growth of transformed cells on the rhodamine-fibronectin substratum resulted in the appearance of discrete negative fluorescent spots beneath the cells and along their migratory paths, whereas a uniform fluorescent carpet was detected with nontransformed cells. The release of radioactivity was partially inhibited by protease inhibitors, including alpha 2-macroglobulin, leupeptin, and benzamidine, but the negative fluorescent spots appeared unaffected by any of these inhibitors. However, both the release of radiolabeled peptides and the appearance of fluorescence-negative spots were inhibited by 1,10-phenanthroline at concentrations that did not affect cellular attachment and protein synthesis, thus supporting a role for proteases in localized degradation of fibronectin substratum. These fluorescence-negative spots coincided with sites of fibronectin disappearance as judged by indirect labeling with antibodies to cellular fibronectin. In addition, immunofluorescent analyses showed a correlation between vinculin localization and the negative fibronectin spots found under transformed cells, indicating that degradation occurs at cell substratum contact sites. These results can be correlated with other transformation-associated phenotypic changes, and are discussed in terms of the invasion of tumor cells into the extracellular matrix.
病毒转化的成纤维细胞显示出蛋白酶产生增加以及细胞外粘附蛋白丧失。为了确定这些与转化相关的事件是否相关,我们使用一种新型交联蛋白基质研究了劳氏肉瘤病毒转化细胞(胚胎鸡成纤维细胞和小鼠BALB/c 3T3)降解纤连蛋白的能力:荧光标记或放射性标记的纤连蛋白共价连接到固定明胶膜表面。在含血清培养基中,偶联的纤连蛋白在无细胞孵育时不会释放,与未转化细胞孵育时仅释放少量。然而,当将转化细胞接种到放射性标记的纤连蛋白偶联基质上时,培养基中放射性随时间的释放增加了三倍。释放的物质被鉴定为分子大小小于30,000道尔顿的肽。相应地,转化细胞在罗丹明 - 纤连蛋白基质上生长导致细胞下方及其迁移路径沿线出现离散的负荧光斑点,而未转化细胞则检测到均匀的荧光毯。放射性的释放被蛋白酶抑制剂部分抑制,包括α2-巨球蛋白、亮抑酶肽和苯甲脒,但负荧光斑点似乎不受任何这些抑制剂的影响。然而,放射性标记肽的释放和荧光负斑点的出现都被1,10 - 菲咯啉抑制,其浓度不影响细胞附着和蛋白质合成,从而支持蛋白酶在纤连蛋白基质局部降解中的作用。这些荧光负斑点与通过针对细胞纤连蛋白的抗体间接标记判断的纤连蛋白消失位点一致。此外,免疫荧光分析显示纽蛋白定位与转化细胞下发现的负纤连蛋白斑点之间存在相关性,表明降解发生在细胞 - 基质接触位点。这些结果可以与其他与转化相关的表型变化相关联,并就肿瘤细胞侵入细胞外基质进行了讨论。